main content start
Onglyza (saxagliptin) is an oral medication in the DPP-4 inhibitor class of drugs. It lowers blood glucose by slowing the inactivation of GLP-1, a compound in the body that lowers blood glucose levels.
It is approved for adults with type 2 diabetes.
- Onglyza is used to improve blood glucose management in adults with type 2 diabetes.
- Along with diet and exercise, it is used to improve blood glucose management in adults with type 2 diabetes.
- It is not for treating type 1 diabetes.
- Taken with or without food, the usual dose of Onglyza is 2.5 or 5 mg taken by mouth once a day.
- Common side effects may include headache or cold-like symptoms.
- Onglyza is generally avoided in people with heart failure.
Onglyza Specs
Key specification
Generic Name
Saxagliptin
Drug Class
DPP-4 inhibitors
General Information
Product Name
Onglyza
Product Type
Oral Medications
Brand
AstraZeneca
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
